These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 1497015

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Anti-beta 2 glycoprotein I antibodies in systemic lupus erythematosus: a marker of thrombosis associated with a circulating anticoagulant].
    Viard JP, Amoura Z, Bach JF.
    C R Acad Sci III; 1991; 313(13):607-12. PubMed ID: 1782567
    [Abstract] [Full Text] [Related]

  • 3. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 4. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.
    McHugh NJ, Moye DA, James IE, Sampson M, Maddison PJ.
    Ann Rheum Dis; 1991 Aug; 50(8):548-52. PubMed ID: 1909518
    [Abstract] [Full Text] [Related]

  • 5. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A.
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V, Verasertniyom O, Vanichapuntu M, Totemchokchyakarn K, Nantiruj K, Pisitkul P, Angchaisuksiri P, Archararit N, Rachakom B, Ayurachai K, Janwityanujit S.
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study.
    Ginsberg JS, Brill-Edwards P, Johnston M, Denburg JA, Andrew M, Burrows RF, Bensen W, Cividino A, Long AA.
    Blood; 1992 Aug 15; 80(4):975-80. PubMed ID: 1498338
    [Abstract] [Full Text] [Related]

  • 10. Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus.
    Sukenik S, el-Roeiy A, Shoenfeld Y.
    Acta Haematol; 1986 Aug 15; 76(2-3):86-9. PubMed ID: 3101368
    [Abstract] [Full Text] [Related]

  • 11. Anticardiolipin antibodies: their presence as a marker for lupus anticoagulant in pregnancy.
    Pattison NS, McKay EJ, Liggins GC, Lubbe WF.
    N Z Med J; 1987 Feb 11; 100(817):61-4. PubMed ID: 3103033
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome.
    Jones DW, MacKie IJ, Gallimore MJ, Winter M.
    Br J Haematol; 2001 May 11; 113(2):550-2. PubMed ID: 11380430
    [Abstract] [Full Text] [Related]

  • 15. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
    Alving BM, Barr CF, Tang DB.
    Am J Med; 1990 Feb 11; 88(2):112-6. PubMed ID: 2105643
    [Abstract] [Full Text] [Related]

  • 16. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B, Tavori S, Lerner M, Tatarsky I, Lorber M.
    Isr J Med Sci; 1992 Jan 11; 28(1):9-15. PubMed ID: 1733904
    [Abstract] [Full Text] [Related]

  • 17. [Clinical significance of antiphospholipid autoantibodies in lupus erythematosus].
    Pozsonyi T, Lakos G, Jakab L, Baraczka K, Jánoskuti L, Kleiber M, Sipka S, Pajor A, Szegedi G.
    Orv Hetil; 1998 Oct 04; 139(40):2363-8. PubMed ID: 9796352
    [Abstract] [Full Text] [Related]

  • 18. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Alessandri C, Bombardieri M, Di Prospero L, Conigliaro P, Conti F, Labbadia G, Misasi R, Sorice M, Valesini G.
    Clin Exp Immunol; 2005 Apr 04; 140(1):173-80. PubMed ID: 15762889
    [Abstract] [Full Text] [Related]

  • 19. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.
    Violi F, Ferro D, Valesini G, Quintarelli C, Saliola M, Grandilli MA, Balsano F.
    BMJ; 1990 Apr 28; 300(6732):1099-102. PubMed ID: 2111722
    [Abstract] [Full Text] [Related]

  • 20. Occlusion of small hepatic veins associated with systemic lupus erythematosus with the lupus anticoagulant and anti-cardiolipin antibody.
    Nakamura H, Uehara H, Okada T, Kambe H, Kimura Y, Ito H, Hayashi E, Yamamoto H, Kishimoto S.
    Hepatogastroenterology; 1989 Oct 28; 36(5):393-7. PubMed ID: 2516008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.